🇨🇦 early initiation of treatment with Risperdal Consta in Canada

early initiation of treatment with Risperdal Consta (early initiation of treatment with Risperdal Consta) regulatory status in Canada.

Marketing authorisation

early initiation of treatment with Risperdal Consta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is early initiation of treatment with Risperdal Consta approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for early initiation of treatment with Risperdal Consta in Canada?

Janssen Pharmaceutica N.V., Belgium is the originator. The local marketing authorisation holder may differ — check the official source linked above.